Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Non-communicable, chronic diseases are currently the major cause of death and disability worldwide, and many of these maladies have reached epidemic proportions. According to the World Health Organization (WHO) these disorders, including cardiovascular and respiratory diseases, diabetes, obesity and cancer, now account for about half of the global disease burden as well as deaths worldwide. The WHO identifies comparatively few risk factors, namely smoking, alcohol abuse, obesity, high cholesterol and high blood pressure, as the cause of many of these chronic conditions. A new class of medicines, based on vaccine approaches, are now in clinical trials and hold significant promise to treat both risk factors and their associated chronic diseases.

Original publication

DOI

10.1016/j.drudis.2006.09.006

Type

Journal article

Journal

Drug Discov Today

Publication Date

11/2006

Volume

11

Pages

1028 - 1033

Keywords

Alzheimer Vaccines, Cardiovascular Diseases, Disease Outbreaks, Forecasting, Global Health, Humans, Obesity, Patient Compliance, Smoking, Smoking Prevention, Vaccination, Vaccines